Document:

Exhibit 10.13

 

EMPLOYMENT AGREEMENT

 

BETWEEN

 

EVGO SERVICES LLC

 

AND

 

IVO STEKLAC

 

JANUARY 15, 2020

 

    

     

    

 

TABLE OF CONTENTS

 

	 	 	Page 
	Section 1.	Employment	2
	Section 2.	Position and Duties	2
	Section 3.	Compensation and Benefits	3
	Section 4.	Term	3
	Section 5.	Executive’s Representations	6
	Section 6.	Deferred Compensation Matters	6
	Section 7.	Non-Compete and Non-solicitation	9
	Section 8.	Confidential Information, Inventions and Intellectual Property Rights	10
	Section 9.	Enforcement	11
	Section 10.	Survival	11
	Section 11.	Notices	11
	Section 12.	Severability	12
	Section 13.	Complete Agreement	12
	Section 14.	No Strict Construction	12
	Section 15.	Counterparts	12
	Section 16.	Successors and Assigns	12
	Section 17.	Choice of Law	12
	Section 18.	Amendment and Waiver	12
	Section 19.	Withholding	13
	SECTION 20.	CONSENT TO JURISDICTION	13
	SECTION 21.	WAIVER OF JURY TRIAL	13
	Section 22.	Corporate Opportunity	14
	Section 23.	Executive’s Cooperation	14

 

    i

     

    

 

EVGO SERVICES LLC

 

EMPLOYMENT AGREEMENT

 

THIS AGREEMENT (“Agreement”)
is made as of January 15, 2020 and is effective as of the date of the closing (the “Closing” or the “Effective
Date”) of the transactions contemplated by that certain Agreement and Plan of Merger by and among EVgo Holdco, LLC, a Delaware
limited liability company, EVgo MergerCo, LLC, a Delaware limited liability company, EVgo Services LLC, a Delaware limited liability company
(and any successor thereto, the “Company”), and the other parties thereto, dated as of December 19, 2019 (the “Merger
Agreement”), between the Company and Ivo Steklac (“Executive”). In the event that the Closing does not occur
or the Merger Agreement is otherwise terminated or abandoned prior to the Closing, then this Agreement shall be null and void ab initio.

 

NOW, THEREFORE, in consideration
of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree as follows:

 

Section 1.       Employment.
The Company shall employ Executive, and Executive hereby accepts employment with the Company, upon the terms and conditions set forth
in this Agreement for the period beginning on the Effective Date and ending as provided in Section 4 (the “Employment
Period”).

 

Section 2.       Position and
Duties.

 

(a)       During
the Employment Period, Executive shall serve as the Chief Operating Officer and Chief Technology Officer and shall have the normal duties,
responsibilities, functions and authority of the Chief Operating Officer and Chief Technology Officer, subject to the power and authority
of EVgo Holding, LLC’s (“Holdings”) board of managers (the “Board”) and the Company’s
Chief Executive Officer (the “CEO”) to expand or limit such duties, responsibilities, functions and authority generally
consistent with Executive’s position. During the Employment Period, Executive shall render such executive and managerial services
to the Company and its Subsidiaries which are consistent with Executive’s position, as the Board or the CEO may from time to time
direct.

 

(b)       During
the Employment Period, Executive shall report to the CEO and shall devote Executive’s best efforts and Executive’s full
business time and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) to the
business and affairs of the Company and its Subsidiaries. Executive shall perform Executive’s duties, responsibilities and
functions for the Company and its Subsidiaries hereunder to the best of Executive’s abilities in a diligent, trustworthy,
legal, professional and efficient manner and shall comply with the Company’s and its Subsidiaries’ policies and
procedures in all material respects. In performing Executive’s duties and exercising Executive’s authority under the
Agreement, Executive shall support and implement the business and strategic plans approved from time to time by the Board and shall
support and cooperate with the Company’s and its Subsidiaries’ efforts to expand their businesses and operate profitably
and in conformity with the business and strategic plans approved by the Board. So long as Executive is employed by the Company,
Executive shall not, without the prior written consent of the Board, accept other employment or perform other services for
compensation. During the Employment Period, Executive shall not serve as an officer or director of, or otherwise perform services
for compensation for, any other person or entity without the prior written consent of the Board and except as set forth on Exhibit B; provided
that Executive may serve as an officer or director of, or otherwise participate in, solely educational, welfare, social, religious,
not-for-profit and civic organizations so long as such activities do not interfere with Executive’s employment with the
Company and its Subsidiaries.

 

    2

     

    

 

Section 3.       Compensation
and Benefits.

 

(a)       During
the Employment Period, Executive’s base salary shall be $309,000 per annum (the “Base Salary”), which salary
shall be payable by the Company in regular installments in accordance with the Company’s general payroll practices in effect from
time to time. During the period beginning on the Effective Date and ending December 31, 2020, the Base Salary shall be pro rated on an
annualized basis. In addition, during the Employment Period, Executive shall be entitled to participate in all of the Company’s
employee benefit programs for which senior executive employees of the Company and its Subsidiaries are generally eligible, including vacation
and paid time off, in accordance with the terms and conditions of the applicable plans and policies.

 

(b)       During
the Employment Period, the Company shall reimburse Executive for all reasonable business expenses incurred by Executive while performing
Executive’s duties and responsibilities under this Agreement which are consistent with the Company’s policies in effect from
time to time with respect to travel, entertainment and other business expenses subject to the Company’s requirements with respect
to reporting and documentation of such expenses.

 

(c)       Executive
shall be eligible to receive an annual incentive payment (the “Bonus Amount”) based on a target bonus opportunity of
50% of Base Salary based upon Executive’s performance and the Company’s achievement of certain objectives as determined by
the CEO (the “Incentive Targets”). The Bonus Amount, if any, shall be paid to the Executive within 30 days after the
Board or the compensation committee determines whether and to what extent Incentive Targets were achieved, but no later than March 15
following the end of the calendar year for which the Bonus Amount, if any, was earned.

 

(d)       All
amounts payable to Executive as compensation hereunder shall be subject to all required and customary withholding by the Company and its
Subsidiaries.

 

Section 4.       Term.

 

(a)       The
Employment Period shall begin on the Effective Date and terminate (any such termination, a “Separation”) on the earliest
to occur of Executive’s (i) resignation with or without Good Reason, (ii) death or Disability or (iii) termination by the Company
at any time (with or without Cause). Except as otherwise permitted or provided herein, any termination of the Employment Period by the
Company shall be effective as of the date specified in a written notice from the Company to Executive.

 

    3

     

    

 

(b)       If
the Employment Period is terminated by the Company without Cause or upon Executive’s resignation with Good Reason, Executive
shall only be entitled to receive Executive’s Base Salary and employee benefits through the date of such termination or
resignation, including any portion of a Bonus Amount earned but unpaid for any previously ended fiscal year as provided in Section 3(c)
that would have payable to Executive if the Employment Period had not been so terminated, and Executive shall not be entitled to any
other salary, bonus, compensation or benefits from the Company or its Subsidiaries thereafter, except as follows:

 

(i)       (x)
if and only if Executive has executed and delivered to the Company a general release, in form annexed as Exhibit A hereto
or as approved by the Board from time to time (the “General Release”), and the General Release has become effective
and is no longer subject to revocation, and only so long as Executive has not revoked or breached the provisions of the General Release
and does not apply for unemployment compensation chargeable to the Company or any Subsidiary during the Severance Period, and (y) subject
to the terms and conditions of Section 6, Executive shall be entitled to receive an amount equal to six months of Executive’s
Base Salary then in effect, payable in regular installments in accordance with the Company’s regular payroll practices, as special
severance payments from the date of such termination for a period of 24 months after the date of such termination without Cause or resignation
with Good Reason (the “Severance Period”).

 

(ii)       Except
as provided in Section 4(b)(i), Executive shall not be entitled to any other salary, compensation or benefits after termination
of the Employment Period, except as otherwise specifically provided for under the Company’s employee benefit plans or as expressly
required by applicable law.

 

(c)       If
the Employment Period is terminated pursuant to clause (a)(ii) above due to Executive’s death or Disability, Executive shall be
entitled to receive Executive’s Base Salary through the date of such termination, including any portion of a Bonus Amount earned
but unpaid for any previously ended fiscal year as provided in Section 3(c) that would have payable to Executive if the Employment
Period had not been so terminated. Executive shall not be entitled to any other salary, compensation or benefits from the Company or its
Subsidiaries thereafter, except as otherwise specifically provided for under the Company’s employee benefit plans or as expressly
required by applicable law.

 

(d)       If
the Employment Period is terminated by the Company for Cause or is terminated pursuant to clause (a)(i) above due to Executive’s
resignation without Good Reason, Executive shall only be entitled to receive Executive’s Base Salary and employee benefits through
the date of such termination and shall not be entitled to any other salary, compensation or benefits from the Company or its Subsidiaries
thereafter, except as otherwise specifically provided for under the Company’s employee benefit plans or as expressly required by
applicable law.

 

(e)       Except
as otherwise expressly provided in this Agreement, all of Executive’s rights to salary, bonuses, employee benefits and other
compensation hereunder which would have accrued or become payable after the termination of the Employment Period shall cease upon
such termination or expiration, other than those expressly required under applicable law (such as COBRA). Nothing contained herein
is intended to limit or otherwise restrict the availability of any COBRA benefits to Executive required to be provided pursuant to
Section 601 of Title I of the Employee Retirement Income Security Act of 1974 and Section 4980B of the Internal Revenue
Code (the “Code”). Except as otherwise provided in Section 6, the Company may offset any amounts
Executive owes it or its Subsidiaries against any amounts it or its Subsidiaries owes Executive hereunder.

 

    4

     

    

 

(f)       “Cause”
shall mean with respect to Executive one or more of the following: (i) the conviction of a felony or other crime involving moral turpitude;
(ii) the commission of any act or omission involving dishonesty, disloyalty or fraud, including with respect to the Company or any of
its Subsidiaries or any of their customers or suppliers; (iii) reporting to work under the impairment of alcohol or drugs, or the use
of illegal drugs (whether or not at the workplace) or other conduct causing the Company or any of its Subsidiaries substantial public
disgrace or disrepute or substantial economic harm; (iv) failure to perform all material duties as reasonably directed by the CEO; (v)
any act or omission aiding or abetting a competitor, supplier or customer of the Company or any of its Subsidiaries whether or not resulting
in a disadvantage or detriment to the Company and its Subsidiaries; (vi) breach of any duty, gross negligence, or willful misconduct with
respect to the Company or any of its Subsidiaries; or (vii) any other material breach of this Agreement.

 

(g)       “Disability”
shall mean Executive’s inability to perform the essential duties, responsibilities and functions of Executive’s position with
the Company and its Subsidiaries for a period of 90 consecutive days or for a total of 180 days during any 12-month period as a result
of any mental or physical illness, disability or incapacity even with reasonable accommodations for such illness, disability or incapacity
provided by the Company and its Subsidiaries or if providing such accommodations would be unreasonable, all as determined by the Board
in its reasonable good faith judgment; provided that if any such Disability would not be a “disability” within the
meaning of Code Section 409A, no payment shall be made hereunder as a result of any such Disability that would be deferred compensation
for purposes of Code Section 409A. Executive shall cooperate in all respects with the Company if a question arises as to whether
Executive has become disabled (including submitting to reasonable examinations by one or more medical doctors and other health care specialists
and authorizing such medical doctors and other health care specialists to discuss Executive’s condition with the Company).

 

(h)       “Good
Reason” shall mean if Executive resigns from employment with the Company and its Subsidiaries prior to the end of the Employment
Period as a result of one or more of the following reasons: (i) the Company reduces the amount of the Base Salary without Executive’s
consent other than as part of a reduction in the salaries of the Company’s executive team as a whole with such reduction being in
the same proportion as the reductions applied to the other executive team members’ base salaries; or (ii) the Company materially
diminishes Executive’s duties or responsibilities; provided that written notice of Good Reason must be delivered to the Company
within 30 days after the occurrence of any such event in order for Executive’s resignation with Good Reason to be effective hereunder
and the Company must have failed to cure such event, to the extent curable, within 60 days following receipt of such notice.

 

(i)       “Person”
means an individual, a partnership, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint
venture, an unincorporated organization, investment fund, any other business entity and a governmental entity or any department, agency
or political subdivision thereof.

 

    5

     

    

 

(j)       “Subsidiary”
means, with respect to any Person, any corporation, limited liability company, partnership, association, or business entity of which (i)
if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency)
to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that
Person or one or more of the other Subsidiaries of that Person or a combination thereof, (ii) if a limited liability company, partnership,
association, or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof
is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination
thereof, or (iii) the management is otherwise controlled directly or indirectly, through one or more intermediaries, by such Person. For
purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership,
association, or other business entity (other than a corporation) if such Person or Persons shall be allocated a majority of limited liability
company, partnership, association, or other business entity gains or losses or shall be or control any managing director or general partner
of such limited liability company, partnership, association, or other business entity. For purposes hereof, references to a “Subsidiary”
of any Person shall be given effect only at such times that such Person has one or more Subsidiaries, and, unless otherwise indicated,
the term “Subsidiary” refers to a Subsidiary of the Company.

 

Section 5.       Executive’s
Representations. Executive hereby represents and warrants to the Company that (i) the execution, delivery and performance of this
Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument,
order, judgment or decree to which Executive is a party or by which Executive is bound, (ii) except as otherwise disclosed herein, Executive
is not a party to or bound by any employment agreement, non-compete agreement or confidentiality agreement with any other person, business
or entity or any agreement or contract requiring Executive to assign inventions to another party, (iii) upon the execution and delivery
of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with
its terms, and (iv) Executive is not subject to any pending, or to Executive’s knowledge any threatened, lawsuit, action, investigation
or proceeding, including with respect to Executive’s prior employment or consulting work or the use of any information or techniques
of any former employer or contracting party. Executive hereby acknowledges and represents that Executive has consulted with independent
legal counsel regarding Executive’s rights and obligations under this Agreement, including Section 7, Section 17,
and Section 20, which have been reviewed in full and consented to, and that Executive fully understands the terms and conditions
contained herein.

 

Section 6       Deferred Compensation
Matters.

 

(a)       It
is the intent of the Company and Executive that the payments and benefits under this Agreement shall comply with Code Section 409A and
the regulations and guidance promulgated thereunder (collectively, “Code Section 409A”), and accordingly, to the maximum
extent permitted, this Agreement shall be interpreted to be in compliance with Code Section 409A. In no event whatsoever shall the Company
be liable for any additional tax, interest or penalty that may be imposed on Executive by Code Section 409A or for any damages for failing
to comply with Code Section 409A.

 

    6

     

    

 

(b)       A
termination of the Employment Period shall not be deemed to have occurred for purposes of any provision of this Agreement providing for
the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation
from service” within the meaning of Code Section 409A, and for purposes of any such provision of this Agreement, references to a
 “termination”, “termination of the Employment Period”, “termination of employment” or similar terms
shall mean “separation from service.”

 

(c)       Notwithstanding
any other payment schedule provided herein to the contrary, if the Executive is deemed on the date of termination of the Employment Period
to be a “specified employee” within the meaning of that term under Code Section 409A, then each of the following shall apply:

 

(i)       With
regard to any payment that is considered “non-qualified deferred compensation” under Code Section 409A payable on account
of a “separation from service,” such payment shall be made on the date which is the earlier of (A) the expiration of the six
(6)-month period measured from the date of such “separation from service” of Executive, and (B) the date of Executive’s
death (the “Delay Period”) to the extent required under Code Section 409A. Upon the expiration of the Delay Period,
all payments delayed pursuant to this Section 6 (whether otherwise payable in a single sum or in installments in the absence
of such delay) shall be paid to Executive in a lump sum, and all remaining payments due under this Agreement shall be paid or provided
for in accordance with the normal payment dates specified herein; and

 

(ii)       To
the extent that any benefits to be provided during the Delay Period are considered “non-qualified deferred compensation” under
Code Section 409A payable on account of a “separation from service,” and such benefits are not otherwise exempt from Code
Section 409A, Executive shall pay the cost of such benefits during the Delay Period, and the Company shall reimburse Executive, to the
extent that such costs would otherwise have been paid by the Company or to the extent that such benefits would otherwise have been provided
by the Company at no cost to Executive, the Company’s share of the cost of such benefits upon expiration of the Delay Period. Any
remaining benefits shall be reimbursed or provided by the Company in accordance with the procedures specified in this Agreement.

 

(d)       To
the extent that severance payments or benefits pursuant to this Agreement are conditioned upon the execution and delivery by the Executive
of the General Release, Executive shall forfeit all rights to such payments and benefits unless such release is signed and delivered (and
no longer subject to revocation, if applicable) within sixty (60) days following the date of the termination of the Employment Period.
If the General Release is executed and delivered and no longer subject to revocation as provided in the preceding sentence, then the following
shall apply:

 

    7

     

    

 

(i)       To
the extent any such cash payments or continuing benefits to be provided are not “non-qualified deferred compensation”
for purposes of Code Section 409A, then such payments or benefits shall commence upon the first scheduled payment date immediately
after the date the General Release is executed and no longer subject to revocation (the “Release Effective
Date”). The first such cash payment shall include all amounts that otherwise would have been due prior thereto under the
terms of this Agreement applied as though such payments commenced immediately upon the termination of the Employment Period, and any
payments made after the Release Effective Date shall continue as provided herein. The delayed benefits shall in any event expire at
the time such benefits would have expired had such benefits commenced immediately following the termination of the Employment
Period.

 

(ii)       To
the extent any such cash payments or continuing benefits to be provided are “non-qualified deferred compensation” for purposes
of Code Section 409A, then such payments or benefits shall be made or commence upon the sixtieth (60th) day following the termination
of the Employment Period. The first such cash payment shall include all amounts that otherwise would have been due prior thereto under
the terms of this Agreement had such payments commenced immediately upon the termination of the Employment Period, and any payments made
after the first such payment shall continue as provided herein. The delayed benefits shall in any event expire at the time such benefits
would have expired had such benefits commenced immediately following the termination of the Employment Period.

 

The Company may provide, in its sole discretion,
that Executive may continue to participate in any benefits delayed pursuant to this Section 6 during the period of such delay;
provided that Executive shall bear the full cost of such benefits during such delay period. Upon the date such benefits would otherwise
commence pursuant to this Section 6, the Company may reimburse Executive for the Company’s share of the cost of such
benefits, to the extent that such costs would otherwise have been paid by the Company or to the extent that such benefits would otherwise
have been provided by the Company at no cost to Executive, in each case had such benefits commenced immediately upon the termination of
the Employment Period. Any remaining benefits shall be reimbursed or provided by the Company in accordance with the schedule and procedures
specified in this Agreement.

 

(e)       To
the extent any reimbursements or in-kind benefits under this Agreement constitute “non-qualified deferred compensation” for
purposes of Code Section 409A, (i) all such expenses or other reimbursements under this Agreement shall be made on or prior to the last
day of the taxable year following the taxable year in which such expenses were incurred by Executive, (ii) any right to reimbursement
or in kind benefits is not subject to liquidation or exchange for another benefit, and (iii) no such reimbursement, expenses eligible
for reimbursement or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or
in-kind benefits to be provided, in any other taxable year.

 

(f)       For
purposes of Code Section 409A, Executive’s right to receive any installment payment pursuant to this Agreement shall be
treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a
payment period with reference to a number of days (e.g., “payment shall be made within thirty (30) days following the
date of termination”), the actual date of payment within the specified period shall be within the Company’s sole
discretion. Notwithstanding any other provision of this Agreement to the contrary, in no event shall any payment under this
Agreement that constitutes “non-qualified deferred compensation” for purposes of Code Section 409A be subject to offset,
counterclaim or recoupment by any other amount unless otherwise permitted by Code Section 409A.

 

    8

     

    

 

Section 7.       Non-Compete
and Non-solicitation.

 

(a)       Executive
acknowledges and agrees that (i) the business of the Company and its Subsidiaries is conducted in North America (collectively, the “Territory”),
(ii) the Company’s and its Subsidiaries’ reputation and goodwill are an integral part of its business success throughout the
Territory, (iii) Executive is familiar with certain of the Company’s and its Subsidiaries’ trade secrets and with other Confidential
Information (as defined herein) concerning the Company and its affiliates, (iv) Executive’s services are of special, unique and
extraordinary value to the Company and its Subsidiaries, and (v) if Executive were to deprive the Company or any of its Subsidiaries of
any of such goodwill or in any manner utilizes such reputation and goodwill in competition with the Company or any of its Subsidiaries,
the Company will be deprived of the benefits it has bargained for in this Agreement. Accordingly, in order to protect such trade secrets,
Confidential Information and goodwill as well as the value of the Company and its Subsidiaries, and as a condition to the Company’s
willingness to enter into this Agreement, Executive agrees that, so long as Executive is employed by the Company or any of its Subsidiaries
and continuing for the period beginning on the date of Executive’s Separation and ending upon the second anniversary of such Separation
(the “Non-compete Period”), Executive shall not, anywhere in the Territory, directly or indirectly own any interest
in, manage, control, participate in, consult with, render services for, be employed in an executive, managerial or administrative capacity
by, or in any manner engage in any business that reasonably purports to compete with the material lines of businesses of the Company or
any of its Subsidiaries, as such businesses (i) currently exist or are currently in the active process of development and (ii) exist or
are in the active process of development during Executive’s employment with the Company or any of its Subsidiaries; provided
that, nothing herein shall prohibit Executive from being a passive owner of not more than 1% of the outstanding stock of any class of
a corporation which is publicly traded, so long as Executive has no participation in the business of such corporation.

 

(b)       During
the Non-compete Period, Executive shall not directly or indirectly through another person or entity (i) induce or attempt to induce any
employee of the Company or any of its Subsidiaries to leave the employ of the Company or any of its Subsidiaries, or in any way interfere
with the relationship between the Company or any of its Subsidiaries and any employee thereof, (ii) hire any person who was an employee
of the Company or any of its Subsidiaries within one year prior to the time such employee was hired by Executive (directly or indirectly
through another person or entity) or (iii) induce or attempt to induce any customer, referral source, supplier, licensee, licensor, franchisee
or other business relation of the Company or any of its Subsidiaries to cease doing business with the Company or any of its Subsidiaries,
or in any way interfere with the relationship between any such customer, supplier, licensee or business relation and the Company or any
of its Subsidiaries.

 

(c)       For
purposes of this Section 7, the term “Company” shall also include Holdings.

 

    9

     

    

 

Section 8.       Confidential
Information, Inventions and Intellectual Property Rights.

 

(a)       Executive
acknowledges that the information, observations and data (including trade secrets) obtained by Executive concerning the business and affairs
of the Company and its Subsidiaries, whether obtained before or after the date of this Agreement, (“Confidential Information”)
are the property of the Company and its Subsidiaries. Executive agrees not to disclose to any person or entity or use for Executive’s
own (or other Person’s) purposes any Confidential Information or any confidential or proprietary information of other persons or
entities in the possession of the Company and its affiliates (“Third Party Information”), without the prior written
consent of the Board unless and to the extent that the Confidential Information or Third Party Information becomes generally known to
and available for use by the public other than as a result of Executive’s direct or indirect acts or omissions. Executive shall
deliver to the Company at the termination or expiration of Executive’s employment, or at any other time the Company may request,
all memoranda, notes, plans, records, reports, computer files, disks and tapes, printouts and software and other documents and data (and
copies thereof) embodying or relating to Third Party Information, Confidential Information, Work Product (as defined below) or the business
of the Company or any of its Subsidiaries that Executive may then possess or have under Executive’s control.

 

(b)       Executive
acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings,
reports, patent applications and copyrightable work (whether or not including any Confidential Information) and all registrations or applications
related thereto, all other proprietary information and all similar or related information (whether or not patentable) that relate to the
Company’s or any of its Subsidiaries’ actual or anticipated business, research and development or existing or future products
or services and that are conceived, developed or made by Executive (whether alone or jointly with others) while employed by the Company
or any of its Subsidiaries, whether before or after the date of this Agreement (“Work Product”), belong to the Company
or one or more of its Subsidiaries. Executive shall promptly disclose such Work Product to the Company and, at the Company’s expense,
perform all actions reasonably requested by the Company (whether during or after Executive’s employment) to establish and confirm
such ownership (including assignments, consents, powers of attorney and other instruments). Executive acknowledges that all Work Product
shall be deemed to constitute “works made for hire” under the U.S. Copyright Act of 1976, as amended.

 

(c)       For
purposes of this Section 8, the term “Company” shall also include Holdings.

 

    10

     

    

 

Section
9.       Enforcement. If, at the time of enforcement of Section 7 or Section 8 of
this Agreement, a court holds that the restrictions stated herein are unreasonable under circumstances then existing, the parties
hereto agree that the maximum period, scope or geographical area reasonable under such circumstances shall be substituted for the
stated period, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum
period, scope and area permitted by law. Because Executive’s services are unique and because Executive has access to
Confidential Information and Work Product, the parties hereto agree that the Company and its Subsidiaries would suffer irreparable
harm from a breach of Section 8 by Executive and that money damages would not be an adequate remedy for any such breach
of this Agreement. Therefore, in the event of a breach or threatened breach of this Agreement, the Company or its successors or
assigns, in addition to other rights and remedies existing in their favor, shall be entitled to specific performance and/or
injunctive or other equitable relief from a court of competent jurisdiction in order to enforce, or prevent any violations of, the
provisions hereof (without posting a bond or other security). If Executive breaches Section 7, the Executive shall
forfeit any further payments under Section 4(b)(i) and the Severance Period shall be deemed to end immediately on the
date of such breach, but the Company shall not be entitled to specific performance and/or injunctive relief. Executive acknowledges
and agrees that the covenants and agreements set forth in this Agreement were a material inducement to the Company to enter into
this Agreement and to perform its obligations hereunder, and that the Company would not obtain the benefit of the bargain set forth
in this Agreement as specifically negotiated by the parties hereto if Executive breached the provisions of this Agreement. Executive
further acknowledges and agrees (i) that due to the proprietary nature of the Company’s and its Subsidiaries’ business,
the restrictions set forth in this Agreement are reasonable as to time and scope and are necessary to ensure the preservation,
protection and continuity of the business, trade secrets and goodwill of the Company and its Subsidiaries and (ii) that Executive
has reviewed the provisions of this Agreement with Executive’s legal counsel.

 

Section 10.       Survival.
Section 4 through Section 23, inclusive, shall survive and continue in full force in accordance with their terms
notwithstanding the termination of the Employment Period.

 

Section 11.       Notices.
Any notice to be given under or by reason of this Agreement shall be in writing and shall be either personally delivered, sent by reputable
overnight courier service or mailed by first class mail, return receipt requested, to the recipient at the address below indicated:

 

Notices to Executive:
At the most recent address on file with the Company,

 

Notices to the Company:

 

EVgo Services LLC

c/o LS Power Equity
Advisors, LLC

1700 Broadway, 35th
Floor

New York, NY 10019

Attention: General
Counsel

 

with a copy (which
copy shall not constitute notice) to:

Milbank LLP

55 Hudson Yards

New York, New York
10001

Attention: William
B. Bice, Esq.

Facsimile: (212) 822-5622

 

or such other address or to the attention of such
other person as the recipient party shall have specified by prior written notice to the sending party. Any notice under this Agreement
shall be deemed to have been given when so delivered, sent or mailed.

 

    11

     

    

 

Section 12.       Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or
rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any
action in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid,
illegal or unenforceable provision had never been contained herein.

 

Section 13.       Complete Agreement.
This Agreement and any other agreements expressly referred to herein embody the complete agreement and understanding among the parties
and supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may
have related to the subject matter hereof in any way.

 

Section 14.       No Strict
Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their
mutual intent, and no rule of strict construction shall be applied against any party. The use of the word “including” shall
mean “including, without limitation.”

 

Section 15.       Counterparts.
This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute
one and the same agreement.

 

Section 16.       Successors
and Assigns. This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive, the Company and their
respective heirs, successors and assigns, except that Executive may not assign Executive’s rights or delegate Executive’s
duties or obligations hereunder without the prior written consent of the Company. The Company may assign this agreement to any of its
affiliates at any time without consent of the Executive.

 

Section 17.       Choice of
Law. All issues and questions concerning the construction, validity, enforcement and interpretation of this Agreement and the exhibits
and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect
to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause
the application of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of
the State of Delaware shall control the interpretation and construction of this Agreement (and all schedules and exhibits hereto), even
though under that jurisdiction’s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would
ordinarily apply.

 

Section
18.       Amendment and Waiver. The provisions of this Agreement may be amended or waived
only with the prior written consent of the Company (as approved by the Board) and Executive, and except as expressly provided
herein, no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the
provisions of this Agreement (including the Company’s right to terminate the Employment Period for Cause) shall affect the
validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this
Agreement.

 

    12

     

    

 

Section 19.       Withholding.
The Company and its Subsidiaries shall be entitled to deduct or withhold from any amounts owing from the Company or any of its Subsidiaries
to Executive any federal, state, local or foreign withholding taxes, excise tax or employment taxes (“Taxes”) imposed
with respect to Executive’s compensation or other payments from the Company or any of its Subsidiaries or Executive’s ownership
interest in the Company (including wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt or vesting
of restricted equity). In the event the Company or any of its Subsidiaries does not make such deductions or withholdings, Executive shall
indemnify the Company and its Subsidiaries for any such Taxes.

 

SECTION 20.  CONSENT TO
JURISDICTION. EACH OF THE PARTIES IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE
DISTRICT OF DELAWARE, THE DELAWARE COURT OF CHANCERY OF THE STATE OF DELAWARE OR ANY OTHER COURT OF THE STATE OF DELAWARE, FOR THE PURPOSES
OF ANY SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR
THEREBY. EACH OF THE PARTIES HERETO FURTHER AGREES THAT SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY U.S. REGISTERED MAIL TO
SUCH PARTY’S RESPECTIVE ADDRESS SET FORTH IN THIS AGREEMENT SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING
IN DELAWARE WITH RESPECT TO ANY MATTERS TO WHICH IT HAS SUBMITTED TO JURISDICTION IN THIS SECTION 20. EACH OF THE PARTIES
HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS
AGREEMENT, ANY RELATED DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT
OF DELAWARE, AND HEREBY AND THEREBY FURTHER IRREVOCABLY AND UNCONDITIONALLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT
THAT ANY SUCH ACTION, SUIT OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

SECTION 21.   WAIVER OF
JURY TRIAL. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER HAVING THE
OPPORTUNITY TO CONSULT WITH LEGAL COUNSEL), THE COMPANY AND EXECUTIVE EACH EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT
OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY.

 

    13

     

    

 

Section
22.       Corporate Opportunity. Executive shall submit to the Board all business,
commercial and investment opportunities, and all offers presented to Executive or of which Executive becomes aware at any time
during the Employment Period, which relate to the business of the Company as it is conducted during the Employment Period
(“Corporate Opportunities”). Unless approved by the Board, Executive shall not accept or pursue, directly or
indirectly, any Corporate Opportunities on Executive’s own behalf.

 

Section 23.       Executive’s
Cooperation. During the Employment Period and thereafter, Executive shall cooperate with the Company and its Subsidiaries in any internal
investigation, any administrative, regulatory or judicial investigation or proceeding or any dispute with a third party as reasonably
requested by the Company (including Executive being available to the Company for interviews and factual investigations, appearing at the
Company’s request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company
all pertinent information and turning over to the Company all relevant documents which are or may come into Executive’s possession).

 

    14

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Employment Agreement as of the date first written above.

 

	 	EVgo Services LLC
	 	 	 
	 	 	 
	 	By:	/s/ David Nanus
	 	Name:	Davis Nanus
	 	Its:	EVP

 

 

	 	/s/ Ivo Steklac
	 	Ivo Steklac

 

Signature Page to Employment Agreement

 

    

     

    

 

EXHIBIT A

 

GENERAL RELEASE

 

I, Ivo Steklac, in consideration
of and subject to the performance by EVgo Services LLC, a Delaware limited liability company (together with its subsidiaries, the “Company”),
of its obligations under my employment agreement, effective as of January 15, 2020 (the “Employment Agreement”), do
hereby release and forever discharge as of the date hereof the Company, all of its Subsidiaries and affiliates, and all present and former
directors, officers, agents, representatives, employees, partners, members, successors and assigns of the Company, its Subsidiaries and
its affiliates and the Company’s direct or indirect owners, including but not limited to EVgo Holdings, LLC (collectively, the “Released
Parties”) to the extent provided below.

 

1.       I
acknowledge and represent that I have received all payments and benefits that I am entitled to receive (as of the date hereof) by virtue
of any employment by the Company.

 

2.       Except
as provided in paragraph 5 below and except for the provisions of the Employment Agreement that expressly survive the termination of my
employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever
discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims,
counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs
and attorneys’ fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date this
General Release becomes effective and enforceable) and whether known or unknown, suspected, or claimed against the Company or any of the
Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected
with my employment with, or my separation or termination from, the Company and its Subsidiaries (including, but not limited to, any allegation,
claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination
in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the
Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act;
the Employee Retirement Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state
or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal
law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices
or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or
any claim for costs, fees, or other expenses, including, without limitation, attorneys’ fees incurred in these matters) (all of
the foregoing collectively referred to herein as the “Claims”).

 

3.       I
represent that I have made no assignment or transfer of any right, claim, demand, cause of action, or other matter covered by paragraph
2 above.

 

4.       I
expressly acknowledge that I am familiar with Section 1542 of the California Civil Code, which provides as follows:

 

    

     

    

 

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH
THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER
MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.

 

I expressly waive and relinquish any and all rights
and benefits which I may have under Section 1542 of the California Civil Code and any similar laws to the fullest extent possible.

 

5.       I
agree that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment
Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation from employment with
the Company shall not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination
in Employment Act of 1967).

 

6.       I
agree that I am waiving all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind
whatsoever (including, without limitation, reinstatement, back pay, front pay, attorneys’ fees and any form of injunctive relief).
Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be waived
under law (including, without limitation, the right to file an administrative charge or participate in an administrative investigation
or proceeding); provided that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution
of such charge or investigation or proceeding.

 

7.       In
signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims hereinabove
mentioned or implied. I expressly consent that this General Release shall be given full force and effect according to each and all of
its express terms and provisions, including, without limitation, those relating to unknown and unsuspected Claims (notwithstanding any
state statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any,
as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential
and material term of this General Release. I further agree that in the event I should bring a Claim seeking damages against the Company
or any other Released Party, or in the event I should seek to recover against the Company or any other Released Party in any Claim brought
by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent permitted
by law. I further agree that I am not aware of any pending claim of the type described in paragraph 2 above as of the execution of this
General Release.

 

8.       I
agree that neither this General Release, nor the furnishing of the consideration for this General Release, shall be deemed or construed
at any time to be an admission by the Company, any other Released Party or myself of any improper or unlawful conduct.

 

9.       I
agree that I will forfeit all amounts payable by the Company and its Subsidiaries pursuant to Section 4(b) of the Employment
Agreement if I challenge the validity of this General Release. I also agree that if I violate this General Release by suing the
Company or any other Released Parties, I shall pay all costs and expenses of defending against the suit incurred by the Released
Parties (including, without limitation, reasonable attorneys’ fees, and return all payments received by me pursuant to the
Section 4(b) of the Employment Agreement).

 

    

     

    

 

10.       I
agree that this General Release is confidential and agree not to disclose any information regarding the terms of this General Release,
except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning or effect hereof or as required
by law, and I shall instruct each of the foregoing not to disclose the same to anyone. Notwithstanding anything herein to the contrary,
each of the parties (and each affiliate and person acting on behalf of any such party) agree that each party (and each employee, representative,
and other agent of such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure
of this transaction contemplated in the Agreement and all materials of any kind (including, without limitation, opinions or other tax
analyses) that are provided to such party or such person relating to such tax treatment and tax structure, but solely to the extent necessary
to comply with any applicable federal or state securities laws. This authorization is not intended to permit disclosure of any other information
including (without limitation) (i) any portion of any materials to the extent not related to the tax treatment or tax structure of this
transaction, (ii) the identities of participants or potential participants in the Agreement, (iii) any financial information (except to
the extent such information is related to the tax treatment or tax structure of this transaction), or (iv) any other term or detail not
relevant to the tax treatment or the tax structure of this transaction.

 

11.       The
non-disclosure provisions in this General Release do not prohibit or restrict me (or my attorney) from responding to any inquiry about
this General Release or its underlying facts and circumstances by the Securities and Exchange Commission, the National Association of
Securities Dealers, Inc., any other self-regulatory organization or governmental entity.

 

12.       I
agree to reasonably cooperate with the Company in any internal investigation, any administrative, regulatory, or judicial proceeding or
any dispute with a third party. I understand and agree that my cooperation may include, but not be limited to, making myself available
to the Company and its Subsidiaries for interviews and factual investigations; appearing at the Company’s request to give testimony
without requiring service of a subpoena or other legal process; volunteering to the Company and its Subsidiaries pertinent information;
and turning over to the Company all relevant documents which are or may come into my possession.

 

13.       I
agree not to disparage the Company, its and its Subsidiaries’ past and present investors, officers, directors or employees or its
affiliates and to keep all confidential and proprietary information about the past or present business affairs of the Company and its
Subsidiaries and its affiliates confidential unless a prior written release from the Company is obtained. I further agree that as of the
date hereof, I have returned to the Company any and all property, tangible or intangible, relating to the Company’s and its Subsidiaries’
business, which I possessed or had control over at any time (including, but not limited to, company-provided credit cards, building or
office access cards, keys, computer equipment, manuals, files, documents, records, software, customer data base and other data) and that
I shall not retain any copies, compilations, extracts, excerpts, summaries or other notes of any such manuals, files, documents, records,
software, customer data base or other data.

 

    

     

    

 

14.       Notwithstanding
anything in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way affect any rights
or claims arising out of any breach by the Company or by any Released Party of the Employment Agreement after the date hereof.

 

15.       Whenever
possible, each provision of this General Release shall be interpreted in, such manner as to be effective and valid under applicable law,
but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or
rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction,
but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein.

 

BY SIGNING THIS
GENERAL RELEASE, I REPRESENT AND AGREE THAT: I HAVE READ IT CAREFULLY;

 

I UNDERSTAND ALL
OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT
ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES
ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED;

 

I VOLUNTARILY CONSENT
TO EVERYTHING IN IT;

 

I HAVE BEEN ADVISED
IN WRITING BY MEANS OF THIS GENERAL RELEASE AGREEMENT TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL
READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION;

 

I HAVE HAD AT LEAST
21 DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE SUBSTANTIALLY IN ITS FINAL FORM ON _______________ __, _______ TO CONSIDER IT AND
THE CHANGES MADE SINCE THE _______________ ___, _______ VERSION OF THIS GENERAL RELEASE ARE NOT MATERIAL AND SHALL NOT RESTART THE REQUIRED
21-DAY PERIOD OR I HAVE ELECTED TO SIGN THIS RELEASE PRIOR TO THE END OF SUCH 21-DAY PERIOD;

 

I UNDERSTAND THAT
I HAVE SEVEN DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL
THE REVOCATION PERIOD HAS EXPIRED;

 

I HAVE SIGNED THIS
GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY ATTORNEY RETAINED TO ADVISE ME WITH RESPECT TO IT; AND

 

    

     

    

 

I AGREE THAT THE
PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED
REPRESENTATIVE OF THE COMPANY AND BY ME.

 

	DATE:	

 

    

     

    

 

EXHIBIT B

 

PERMITTED OUTSIDE ACTIVITIES

 

Executive is permitted to engage with the following
organizations in the capacities listed below so long as such engagements do not (individually or in the aggregate) involve more than a
de minimis amount of time, do not interfere with Executive's duties to the Company or create a conflict of interest, and so long as the
following organizations are not in competition with the Company. Any increase in Executive's engagement with the following organizations
to a more than a de minimis level will require the prior consent of the Board.

 

		·	Potential startup (non-registered entity) working on human motion recognition and assessment for performance
enhancement, injury prevention, and injury recovery

 

		·	Board of Directors of InfiSwift, a Bay Area IoT and Machine Learning company focused on real-time industrial
applications

 

		·	Startup/incubation mentor/advisor directly or via angel investing networks such as Rockies Venture Club
(RVC)

 

		·	Industry advisor (automotive, autonomous vehicles) to Key Bank Mosaic programExhibit 4.4

 

WARRANT AGREEMENT

 

REVOLUTION ACCELERATION ACQUISITION CORP II

and

CONTINENTAL STOCK TRANSFER & TRUST COMPANY

 

Dated [●], 2021

 

THIS WARRANT AGREEMENT (this “Agreement”),
dated [●], 2021, is by and between Revolution Acceleration Acquisition Corp II, a Delaware corporation (the “Company”),
and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, the
“Warrant Agent”).

 

WHEREAS, it is proposed that the Company enter
into that certain Private Placement Warrants Purchase Agreement with RAAC Management II LLC, a Delaware limited liability company (the
“Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 3,500,000 warrants (or up to 3,875,000
warrants depending on the extent to which the underwriters in the Offering (defined below) exercise their Over-allotment Option (as defined
below)) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable), bearing the legend
set forth in Exhibit B hereto (the “Private Placement Warrants”) at a purchase price of $2.00 per Private
Placement Warrant. Each Private Placement Warrant entitles the holder thereof to purchase one share of Common Stock (as defined below)
at a price of $11.50 per share, subject to adjustment as described herein; and

 

WHEREAS, in order to finance the Company’s
transaction costs in connection with an intended initial merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination, involving the Company and one or more businesses (a “Business Combination”),
the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan
the Company funds as the Company may require, of which up to $2,000,000 of such loans may be convertible into up to an additional 1,000,000
Private Placement Warrants at a price of $2.00 per Private Placement Warrant; and

 

WHEREAS, the Company is engaged in an initial public
offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one
share of Common Stock and one-fourth of one Public Warrant (as defined below) (the “Units”) and, in connection
therewith, has determined to issue and deliver up to 7,187,500 redeemable warrants (including up to 937,500 redeemable warrants subject
to the Over-allotment Option) to public investors in the Offering (the “Public Warrants” and, together with
the Private Placement Warrants, the “Warrants”). Each whole Warrant entitles the holder thereof to purchase
one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), for $11.50 per
share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Public Warrants will not be able
to exercise any fraction of a Warrant; and

 

WHEREAS, the Company has filed with the Securities
and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-253984 (the “Registration
Statement”) and a prospectus (the “Prospectus”), for the registration, under the Securities Act
of 1933, as amended (the “Securities Act”), of the Units, the Public Warrants and the Common Stock included
in the Units; and

 

     

     

    

 

WHEREAS, the Company desires the Warrant Agent
to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants; and

 

WHEREAS, the Company desires to provide for the
form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of
rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and
performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize
the execution and delivery of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual
agreements herein contained, the parties hereto agree as follows:

 

1. Appointment
of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant
Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

 

2. Warrants.

 

2.1 Form
of Warrant. Each Warrant shall initially be issued in registered form only.

 

2.2 Effect
of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement,
a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3 Registration.

 

2.3.1 Warrant
Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Warrant Agent
shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance
with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown
on, and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with The Depository
Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

 

    2

     

    

 

If the Depositary subsequently ceases to make its
book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements
for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public
Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant
Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive
certificates in physical form evidencing such Warrants (“Definitive Warrant Certificates”) which shall be in
the form annexed hereto as Exhibit A.

 

Physical certificates, if issued, shall be signed
by, or bear the facsimile signature of, the Chief Executive Officer or other principal officer of the Company. In the event the person
whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the
Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of
issuance.

 

2.3.2 Registered
Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat
the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the
absolute owner of such Warrant and of each Warrant represented thereby, for the purpose of any exercise thereof, and for all other purposes,
and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4 Detachability
of Warrants. The shares of Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following
the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New
York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business
Day following such date, or earlier (the “Detachment Date”) with the consent of Credit Suisse Securities (USA)
LLC, but in no event shall the shares of Common Stock and the Public Warrants comprising the Units be separately traded until (A) the
Company has filed a Current Report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company
of the gross proceeds of the Offering, including the proceeds then received by the Company from the exercise by the underwriters of their
right to purchase additional Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option
is exercised prior to the filing of the Current Report on Form 8-K, and (B) the Company issues a press release announcing when such separate
trading shall begin.

 

2.5 Fractional
Warrants. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one share
of Common Stock and one-fourth of one whole Public Warrant. If, upon the detachment of Public Warrants from the Units or otherwise, a
holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number
of Warrants to be issued to such holder.

 

2.6 Private
Placement Warrants. The Private Placement Warrants shall be identical to the Public Warrants, except that (i) the Private Placement
Warrants may be exercised for cash or on a “cashless basis,” pursuant to subsection 3.3.1(c) hereof, (ii) the Private
Placement Warrants (and shares of Common Stock issuable upon exercise of the Private Placement Warrants) may be subject to certain transfer
restrictions contained in the letter agreement by and between the Company and each of the Sponsor and other parties thereto, as may be
amended from time to time, including that any permitted transferees must enter into a written agreement with the Company agreeing to be
bound by the transfer restrictions contained in such letter agreement, (iii) the Private Placement Warrants shall not be redeemable by
the Company pursuant to Section 6.1 hereof and (iv) the holders of the Private Placement Warrants (including the shares of
Class A common stock issuable upon exercise of such warrants) are entitled to registration rights.

 

    3

     

    

 

3. Terms
and Exercise of Warrants.

 

3.1 Warrant
Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement,
to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments
provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price”
as used in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a “cashless exercise,”
to the extent permitted or required hereunder) described in the prior sentence at which shares of Common Stock may be purchased at the
time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as
defined below) for a period of not less than twenty (20) Business Days (unless otherwise required by the Commission, any national securities
exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least three (3) days’
prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall
be identical among all of the Warrants.

 

3.2 Duration
of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) (A) commencing
on the later of (i) the date that is thirty (30) days after the first date on which the Company completes a Business Combination and (ii)
the date that is twelve (12) months from the date of the closing of the Offering, and (B) terminating at the earliest to occur of
(x) 5:00 p.m., New York City time on the date that is five (5) years after the date on which the Company completes its initial Business
Combination, (y) the liquidation of the Company in accordance with the Company’s amended and restated certificate of incorporation,
as amended from time to time, if the Company fails to complete a Business Combination, and (z) other than with respect to the Private
Placement Warrants, 5:00 p.m., New York City time on the Redemption Date (as defined below) as provided in Section 6.2 hereof (the
“Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the
satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below, with respect to an effective registration statement
or a valid exemption therefrom being available. Except with respect to the right to receive the Redemption Price (as defined below) (other
than with respect to a Private Placement Warrant) in the event of a redemption (as set forth in Section 6 hereof), each Warrant
(other than a Private Placement Warrant in the event of a redemption) not exercised on or before the Expiration Date shall become void,
and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration
Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that
the Company shall provide at least twenty (20) days’ prior written notice of any such extension to Registered Holders of the Warrants
and, provided further that any such extension shall be identical in duration among all the Warrants.

 

    4

     

    

 

3.3 Exercise
of Warrants.

 

3.3.1 Payment.
Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder thereof by delivering
to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised,
or, in the case of a Warrant represented by a book-entry, the Warrants to be exercised (the “Book-Entry Warrants”)
on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the Warrant
Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) any shares
of Common Stock pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the
Definitive Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the Participant in accordance with the Depositary’s
procedures, and (iii) the payment in full of the Warrant Price for each share of Common Stock as to which the Warrant is exercised and
any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common
Stock and the issuance of such shares of Common Stock, as follows:

 

(a) in
lawful money of the United States, in good certified check or wire payable to the Warrant Agent;

 

(b) in
the event of a redemption pursuant to Section 6.1 hereof in which the Company’s board of directors (the “Board”)
has elected to require all holders of the Public Warrants to exercise such Public Warrants on a “cashless basis,” by surrendering
the Public Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number
of shares of Common Stock underlying the Public Warrants, multiplied by the difference between the Warrant Price and the “Fair Market
Value”, as defined in this subsection 3.3.1(b), by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(b)
and Section 6.1, the “Fair Market Value” shall mean the average last reported sale price of the shares of Common Stock
as reported during the ten (10) trading day period ending on the trading day prior to the date on which the notice of redemption is sent
to the holders of the Warrants pursuant to Section 6.2 hereof;

 

(c) with
respect to any Private Placement Warrant, by surrendering the Warrants for that number of shares of Common Stock equal to the quotient
obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the excess of the
“Sponsor Exercise Fair Market Value” (as defined in this subsection 3.3.1(c)) less the Warrant Price by (y) the Sponsor
Exercise Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Sponsor Exercise Fair Market Value”
shall mean the average last reported sale price of the shares of Common Stock for the ten (10) trading days ending on the third (3rd)
trading day prior to the date on which notice of exercise of the Private Placement Warrant is sent to the Warrant Agent; or

 

(d) as
provided in Section 7.4 hereof.

 

    5

     

    

 

3.3.2 Issuance
of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in
payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder
of such Warrant a book-entry position or certificate, as applicable, for the number of shares of Common Stock to which he, she or it is
entitled, registered in such name or names as may be directed by him, her or it on the share transfer books of the Company, and if such
Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares
as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any
shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration
statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus
relating thereto is current, or a valid exemption from registration is available. No Warrant shall be exercisable and the Company shall
not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the shares of Common Stock issuable upon such Warrant
exercise have been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state
of residence of the Registered Holder of the Warrants. Subject to Section 4.6 of this Agreement, a Registered Holder of Warrants
may exercise its Warrants only for a whole number of shares of Common Stock. The Company may require holders of Public Warrants to settle
their Public Warrants on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a
“cashless basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional
interest in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to
be issued to such holder.

 

3.3.3 Valid
Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement and the amended
and restated certificate of incorporation, shall be validly issued, fully paid and nonassessable.

 

3.3.4 Date
of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued
shall for all purposes be deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant,
or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date
of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date
when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have
become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books
or book-entry system are open.

 

3.3.5 Maximum
Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained
in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she
or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such
person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess
of 9.8% or such other amount as a holder may specify (the “Maximum Percentage”) of the shares of Common Stock
outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of
Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common Stock issuable upon exercise
of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would
be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates
and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by
such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject
to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence,
for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding
shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s
most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission
as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or Continental Stock Transfer
& Trust Company, as transfer agent (in such capacity, the “Transfer Agent”), setting forth the number of
shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall,
within two Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then outstanding. In any case,
the number of issued and outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of equity
securities of the Company by the holder and its affiliates since the date as of which such number of issued and outstanding shares of
Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum
Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such
increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

    6

     

    

 

4. Adjustments.

 

4.1 Stock
Dividends.

 

4.1.1 Split-Ups.
If after the date hereof, and subject to the provisions of Section 4.6 below, the number of issued and outstanding shares of Common
Stock is increased by a stock dividend of shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then,
on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of
each Warrant shall be increased in proportion to such increase in the issued and outstanding shares of Common Stock. A rights offering
made to all holders of shares of Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Historical
Fair Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product
of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold
in such rights offering that are convertible into or exercisable for the shares of Common Stock) multiplied by (ii) one (1) minus the
quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Historical Fair Market Value. For
purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for shares of Common
Stock, in determining the price payable for shares of Common Stock, there shall be taken into account any consideration received for such
rights, as well as any additional amount payable upon exercise or conversion and (ii) “Historical Fair Market Value”
means the volume weighted average price of the shares of Common Stock during the ten (10) trading day period ending on the trading day
prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way,
without the right to receive such rights. No shares of Common Stock shall be issued at less than their par value.

 

4.1.2 Extraordinary
Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all holders of Common Stock a dividend
or make a distribution in cash, securities or other assets on account of such shares of Common Stock (or other shares into which the Warrants
are convertible), other than (a) as described in subsection 4.1.1 above, (b) Ordinary Cash Dividends (as defined below), (c) to
satisfy the redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination, (d) to satisfy
the redemption rights of the holders of the Common Stock in connection with a stockholder vote to amend the Company’s amended and
restated certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection
with the Company’s initial Business Combination or to redeem 100% of the Company’s public shares if it does not complete its
initial Business Combination within the time period required by the Company’s amended and restated certificate of incorporation,
as amended from time to time, or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business
Combination activity or (e) in connection with the redemption of public shares upon the failure of the Company to complete its initial
Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded event being referred to
herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after
the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the Board, in
good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes
of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which,
when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the shares of
Common Stock during the 365-day period ending on the date of declaration of such dividend or distribution to the extent it does not exceed
$0.50 (which amount shall be adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4
and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of shares of Common
Stock issuable on exercise of each Warrant).

 

4.2 Aggregation
of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of issued and outstanding
shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock
or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar
event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in
issued and outstanding shares of Common Stock.

 

4.3 Adjustments
in Exercise Price. Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided
in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such
Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock
purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number
of shares of Common Stock so purchasable immediately thereafter.

 

    7

     

    

 

4.4 Raising
of the Capital in Connection with the Initial Business Combination. If (x) the Company issues additional shares of Common Stock or
equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price
or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined
in good faith by the Board and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any shares
of Class B common stock, par value $0.0001 per share, of the Company or shares of Class C common stock, par value $0.0001 per share, of
the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”),
(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available
for the funding of the Company’s initial Business Combination on the date of the completion of the Company’s initial Business
Combination (net of redemptions), and (z) the volume-weighted average trading price of the Common Stock during the twenty (20) trading
day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price,
the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be
equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described
in Section 6.1 shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued
Price. If the adjustment in the immediately preceding sentence would otherwise result in an increase in the Warrant Price (as adjusted
for stock splits, stock dividends, stock combinations, recapitalizations, Extraordinary Dividends and similar events) hereunder, no adjustment
shall be made.

 

4.5 Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the issued and outstanding shares of
Common Stock (other than a change under Section 4.1 or Section 4.2 hereof or that solely affects the par value of such shares
of Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation (other than a merger or
consolidation in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of
the issued and outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets
or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the
holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified
in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise
of the rights represented thereby, the kind and amount of shares, stock or other equity securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the
holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the
“Alternative Issuance”); provided, however, that (i) if the holders of the Common Stock were entitled
to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such merger or consolidation,
then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become
exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in
such merger or consolidation that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been
made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection
with redemption rights held by stockholders of the Company as provided for in the Company’s amended and restated certificate of
incorporation or as a result of the redemption of shares of Common Stock by the Company if a proposed initial Business Combination is
presented to the stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer,
the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker
is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act) and any
members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under
the Exchange Act) securities representing more than 50% of the aggregate voting power represented by the issued and outstanding equity
securities of the Company, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash,
securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised
the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the shares of Common Stock held by
such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such
tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; provided further
that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the form
of stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter
market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises
the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant
to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference
of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event
less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value”
means (i) for Public Warrants, the value of a Public Warrant immediately prior to the consummation of the applicable event based on the
Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”)
and (ii) for Private Placement Warrants, the value of a Private Placement Warrant immediately prior to the consummation of the applicable
event based on the Black-Scholes Warrant Model for an uncapped American Call on Bloomberg, in each case, as calculated by an accounting,
appraisal, investment banking firm or consultant of nationally recognized standing that is, in the good faith judgment of the Board, qualified
to make such calculation. For purposes of calculating such amount, (i) Section 6 of this Agreement shall be taken into account,
(ii) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock during the ten (10) trading
day period ending on the trading day prior to the effective date of the applicable event, (iii) the assumed volatility shall be the 90
day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement
of the applicable event and (iv) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to
the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders
of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the
volume weighted average price of the Common Stock during the ten (10) trading day period ending on the trading day prior to the effective
date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by
subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and
this Section 4.5. The provisions of this Section 4.5 shall similarly apply to successive reclassifications, reorganizations,
mergers or consolidations, sales or other transfers. In no event shall the Warrant Price be reduced to less than the par value per share
issuable upon exercise of such Warrant.

 

    8

     

    

 

4.6 Notices
of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant, the
Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment
and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting forth
in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified
in Sections 4.1, 4.2, 4.3, 4.4, 4.5 or 4.9, the Company shall give written notice of the occurrence
of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or
the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such
event.

 

4.7 No
Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional
shares upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant
would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise,
round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

 

4.8 Form
of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant
to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form
of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or
countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.9 Other
Events. In case any event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this
Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid
an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company
shall appoint a firm of independent registered public accountants, investment banking or other appraisal firm of recognized national standing,
which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate
the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment;
provided, however, that under no circumstances shall the Warrants be adjusted pursuant to this Section 4.9 as a result
of any issuance of securities in connection with a Business Combination. The Company shall adjust the terms of the Warrants in a manner
that is consistent with any adjustment recommended in such opinion.

 

    9

     

    

 

5. Transfer
and Exchange of Warrants.

 

5.1 Registration
of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register,
upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions
for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant
shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant
Agent to the Company from time to time upon request.

 

5.2 Procedure
for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the
Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise
provided herein or with respect to any Book-Entry Warrant, each Book-Entry Warrant may be transferred only in whole and only to the Depositary,
to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further, however,
that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case, initially, of the Private Placement
Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3 Fractional
Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance
of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

 

5.4 Service
Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5 Warrant
Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms
of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required
by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

    10

     

    

 

5.6 Transfer
of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which
such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore,
each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding
the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment
Date.

 

6. Redemption.

 

6.1 Redemption
of Public Warrants for Cash or Common Stock. Not less than all of the outstanding Public Warrants may be redeemed for cash, at the
option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders
of the Public Warrants, as described in Section 6.2 below, at a Redemption Price of $0.01 per Public Warrant, provided that
(a) the Reference Value (as defined below) equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4
hereof) and (b) there is an effective registration statement covering the issuance of the shares of Common Stock issuable upon exercise
of the Public Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section
6.2 below), or the Company has elected to require the exercise of the Public Warrants on a “cashless basis” pursuant to
subsection 3.3.1(b) hereof.

 

6.2 Date
Fixed for, and Notice of, Redemption; Redemption Price; Reference Value. In the event that the Company elects to redeem the Public
Warrants pursuant to Section 6.1, the Company shall fix a date for the redemption (the “Redemption Date”).
Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the Redemption
Date (the period lasting from such time until the Redemption Date, the “30-day Redemption Period”) to the Registered
Holders of the Public Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed
in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered Holder received such
notice. As used in this Agreement, (a) “Redemption Price” shall mean the price per Warrant at which any
Warrants are redeemed pursuant to Section 6.1 and (b) “Reference Value” shall mean the last reported
sale price of the shares of Common Stock for any twenty (20) trading days within the thirty (30) trading day period ending on the third
(3rd) trading day prior to the date on which notice of the redemption is given.

 

6.3 Exercise
After Notice of Redemption

 

. The Public Warrants may be exercised for cash (or on a “cashless
basis” in accordance with subsection 3.3.1(b) of this Agreement) at any time after notice of redemption shall have been given
by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date. In the event that the Company determines to require
all holders of Warrants to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1, the notice of
redemption shall contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise of the
Warrants, including the “Fair Market Value” (as such term is defined in subsection 3.3.1(b) hereof) in such case. On
and after the Redemption Date, the record holder of the Public Warrants shall have no further rights except to receive, upon surrender
of the Public Warrants, the Redemption Price.

 

    11

     

    

 

7. Other
Provisions Relating to Rights of Holders of Warrants.

 

7.1 No
Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company,
including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other
matter.

 

7.2 Lost,
Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or
destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3 Reservation
of Shares of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares
of Common Stock that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4 Registration
of Shares of Common Stock; Cashless Exercise at Company’s Option.

 

7.4.1 Registration
of the shares of Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days
after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a
registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants.
The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) Business Days following
the closing of its initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus
relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such
registration statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the Business
Combination, holders of the Public Warrants shall have the right, during the period beginning on the sixty-first (61st) Business
Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission,
and during any other period when the Company shall fail to have maintained an effective registration statement covering the issuance of
the shares of Common Stock issuable upon exercise of the Public Warrants, to exercise such Public Warrants on a “cashless basis,”
by exchanging the Public Warrants (in accordance with Section 3(a)(9) of the Securities Act or another exemption) for that number of shares
of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Public
Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) less the Warrant Price by (y) the Fair Market
Value. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall mean the volume-weighted
average price of the shares of Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the
date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary.
The date that notice of “cashless exercise” is received by the Warrant Agent shall be conclusively determined by the Warrant
Agent. In connection with the “cashless exercise” of a Public Warrant, the Company shall, upon request, provide the Warrant
Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i)
the exercise of the Public Warrants on a “cashless basis” in accordance with this subsection 7.4.1 is not required
to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under
United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act)
of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in subsection 7.4.2, for
the avoidance of doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue to be obligated
to comply with its registration obligations under the first three sentences of this subsection 7.4.1.

 

    12

     

    

 

7.4.2 Cashless
Exercise at Company’s Option. If the shares of Common Stock are at the time of any exercise of a Public Warrant not listed on
a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the
Securities Act, the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public
Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act as described in subsection 7.4.1
and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration statement
for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants, notwithstanding
anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify for sale the shares
of Common Stock issuable upon exercise of the Public Warrant under applicable blue sky laws to the extent an exemption is not available.

 

8. Concerning
the Warrant Agent and Other Matters.

 

8.1 Payment
of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant
Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be
obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2 Resignation,
Consolidation, or Merger of Warrant Agent.

 

8.2.1 Appointment
of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged
from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office
of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor
Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after
it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with
such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court
of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing
under the laws of the State of New York, in good standing and having its principal office in the United States of America, and authorized
under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason
it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon
request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties,
and obligations.

 

    13

     

    

 

8.2.2 Notice
of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the
predecessor Warrant Agent and the Transfer Agent for the shares of Common Stock not later than the effective date of any such appointment.

 

8.2.3 Merger
or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any
entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under
this Agreement without any further act.

 

8.3 Fees
and Expenses of Warrant Agent.

 

8.3.1 Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.

 

8.3.2 Further
Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and
delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying
out or performing of the provisions of this Agreement.

 

8.4 Liability
of Warrant Agent.

 

8.4.1 Reliance
on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or
desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact
or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
by a statement signed by the Chief Executive Officer of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon
such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

 

    14

     

    

 

8.4.2 Indemnity.
The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable
outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the
Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

 

8.4.3 Exclusions.
The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any
covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments
required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the
ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any
representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement
or any Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and nonassessable.

 

8.5 Acceptance
of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms
and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise
of the Warrants.

 

8.6 Waiver.
The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date
hereof, by and between the Company and Continental Stock Transfer & Trust Company as trustee thereunder) and hereby agrees not to
seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent
hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

9. Miscellaneous
Provisions.

 

9.1 Successors.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the
benefit of their respective successors and assigns.

 

    15

     

    

 

9.2 Notices.
Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant
to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
by the Company with the Warrant Agent), as follows:

 

Revolution Acceleration Acquisition Corp II

1717 Rhode Island Avenue, NW 10th floor

Washington, D.C. 20036

Attention: Chief Executive Officer

 

Any notice, statement or demand authorized by this Agreement to be
given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered
if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice,
postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer & Trust Company

One State Street, 30th Floor

New York, NY 10004

Attention: Compliance Department

 

9.3 Applicable
Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in
all respects by the laws of the State of New York. Subject to applicable law, the Company hereby agrees that any action, proceeding or
claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New
York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be the exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to
suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of
the United States of America are the sole and exclusive forum.

 

Any person or entity purchasing or otherwise acquiring
any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.
If any action, the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court located
within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”)
in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state
and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection
with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y)
having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel
in the foreign action as agent for such warrant holder.

 

    16

     

    

 

9.4 Persons
Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation
or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason
of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises,
and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Warrants.

 

9.5 Examination
of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in
the United States of America, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to
submit such holder’s Warrant for inspection by the Warrant Agent.

 

9.6 Counterparts.
This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7 Effect
of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation
thereof.

 

9.8 Amendments.
This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of (i) curing any ambiguity
or correcting any mistake, including conforming the provisions hereof to the description of the terms of the Warrants and this Agreement
set forth in the Prospectus, or defective provision contained herein, (ii) removing or reducing the Company’s ability to redeem
the Public Warrants, or (iii) adding or changing any provisions with respect to matters or questions arising under this Agreement as the
parties may deem necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered Holders under
this Agreement in any material respect. All other modifications
or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise Period, (a) with respect
to the terms of the Public Warrants or any provision of this Agreement with respect to the Public Warrants, shall require the vote or
written consent of the Registered Holders of at least 50% of the then outstanding Public Warrants and (b) with respect to the terms of
the Private Placement Warrants or any provision of this Agreement with respect to the Private Placement Warrants shall require the vote
or written consent of at least 50% of the then outstanding Private Placement Warrants. Notwithstanding the foregoing, the Company may
lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without
the consent of the Registered Holders.

 

9.9 Severability.
This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

Exhibit A Form of Warrant Certificate

Exhibit B Legend — Private Placement Warrants

 

    17

     

    

 

IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed as of the date first above written.

 

	 	REVOLUTION ACCELERATION ACQUISITION CORP II
	 	 
	 	By:	 
	 	 	Name: 	John K. Delaney
	 	 	Title:	Chief Executive Officer

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	                              
	 	 	Name:
	 	 	Title:

 

[Signature Page to Warrant Agreement]

  

     

     

    

 

EXHIBIT A

 

[FACE]

 

Number

 

Warrants

 

THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

IN THE WARRANT AGREEMENT DESCRIBED BELOW

 

Revolution Acceleration Acquisition Corp II

Incorporated Under the Laws of the State of
Delaware

 

CUSIP 76156X 117

Warrant Certificate

 

This Warrant Certificate certifies that
      , or registered assigns, is
the registered holder of       warrant(s)
(the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock,
$0.0001 par value (“Common Stock”), of Revolution Acceleration Acquisition Corp II, a Delaware corporation (the
“Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement
referred to below, to receive from the Company that number of fully paid and nonassessable shares of Common Stock as set forth below,
at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful
money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America
upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to
below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not
defined herein shall have the meanings given to them in the Warrant Agreement.

 

Each whole Warrant is initially exercisable for
one fully paid and non-assessable share of Common Stock. Fractional shares shall not be issued upon exercise of any Warrant. If, upon
the exercise of Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon
exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Warrant holder. The number of
shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth
in the Warrant Agreement.

 

The initial Exercise Price per one share of Common
Stock for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of certain events
as set forth in the Warrant Agreement.

 

Subject to the conditions set forth in the Warrant
Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period,
such Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement.

 

     

     

    

 

Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as
though fully set forth at this place.

 

This Warrant Certificate shall not be valid unless
countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

 

This Warrant Certificate shall be governed by and
construed in accordance with the internal laws of the State of New York.

 

	 	REVOLUTION ACCELERATION ACQUISITION CORP II
	 	 
	 	By:	                              
	 	 	Name:
	 	 	Title:

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT
	 	 	 
	 	By:	                              
	 	 	Name:
	 	 	Title:

 

     

     

    

 

[Form of Warrant Certificate]

 

[Reverse]

 

The Warrants evidenced by this Warrant Certificate
are part of a duly authorized issue of Warrants entitling the holder on exercise to receive
shares of Common Stock and are issued or to be issued pursuant to a Warrant Agreement dated as of [●], 2021 (the “Warrant
Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation,
as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made
a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities
thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
meaning the Registered Holders or Registered Holder, respectively) of the Warrants. A copy of the Warrant Agreement may be obtained by
the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have
the meanings given to them in the Warrant Agreement.

 

Warrants may be exercised at any time during the
Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by
surrendering this Warrant Certificate, with the form of Election to Purchase set forth hereon properly completed and executed, together
with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as
provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby, the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there
shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

 

Notwithstanding anything else in this Warrant Certificate
or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the issuance
of the shares of Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating
to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant
Agreement or another exemption from registration is available.

 

The Warrant Agreement provides that upon the occurrence
of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject
to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest
in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of Common Stock to be issued
to the holder of the Warrant.

 

Warrant Certificates, when surrendered at the principal
corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney duly authorized
in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any
service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants.

 

Upon due presentation for registration of transfer
of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing
in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the
limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith.

 

The Company and the Warrant Agent may deem and
treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership
or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for
all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants
nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

 

     

     

    

 

Election to Purchase

(To Be Executed Upon Exercise of Warrant)

 

The undersigned hereby irrevocably elects to exercise
the right, represented by this Warrant Certificate, to receive      shares of
Common Stock and herewith tenders payment for such shares of Common Stock to the order of Revolution Acceleration Acquisition Corp II
(the “Company”) in the amount of $     in accordance
with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered in the name of         ,
whose address is      and that such shares of Common Stock be delivered to     
      whose address is    .
If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests
that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of    ,
whose address is                   and that such Warrant Certificate
be delivered to    , whose address is    .

 

In the event that the Warrant is a Private Placement
Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the
number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c)
of the Warrant Agreement.

 

In the event that the Warrant is to be exercised
on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this
Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

 

In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant is
exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise
and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented
by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If
said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder (after giving effect to the
cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common
Stock be registered in the name of    , whose address
is                   and that such Warrant Certificate be delivered
to    , whose address is.

 

[Signature Page Follows]

 

     

     

    

	Date:                   ,
20	
	 	(Signature)
	 	 
	 	(Address)
	 	 
	 	________________________
	 	(Tax Identification Number)

 

Signature Guaranteed:

________________________________

 

THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED).

 

     

     

    

 

EXHIBIT B

 

LEGEND

 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS
AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT (THE “LETTER AGREEMENT”)
BY AND BETWEEN REVOLUTION ACCELERATION ACQUISITION CORP II (THE “COMPANY”) AND EACH OF RAAC MANAGEMENT II LLC AND THE OTHER
PARTIES THERETO, THE SECURITIES REPRESENTED HEREBY MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE
DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN THE RECITALS OF THE WARRANT AGREEMENT REFERRED TO
HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DESCRIBED IN SECTION 7(D) OF THE LETTER AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY
TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES EVIDENCED HEREBY AND SHARES OF CLASS A COMMON STOCK OF THE
COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED
BY THE COMPANY.

 

		NO.	WARRANT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]